Anton Tjust is an resident physician at the University Hospital of Uppsala and an affiliated researcher at Umeå University. His research area is amyotrophic lateral sclerosis (ALS).
Anton Tjust is a resident physician pursuing a specialization in clinical neurophysiology at the University Hospital of Uppsala, Sweden. He is also affiliated with Umeå University through his research on amyotrophic lateral sclerosis (abbreviated as ALS) and is a member of the Peter Andersen lab. Anton has a medical degree from Umeå University and a PhD degree in medicine. The title of his thesis was Extraocular Muscles in Amyotrophic Lateral Sclerosis and he defended his thesis in the spring of 2017.
In addition to his peer-reviewed research articles, Anton has also written a popular science article on ALS and the Extraocular muscles that was published in The Ophthalmologist.
Parts of his post-doc project concern the treatment of patient-derived fibroblasts with ALS candidate drugs. Together with other members of the ALS research consortium in Umeå, Anton is trying to understand the cell-autonomous effects that candidate drugs have on patient-derived cells and whether some drug effects are restricted to specific sub-types of ALS. His work on human fibroblasts also involves work with the surgical research consortium CLISTER where he studies the roles of fibroblasts in connective tissue reorganization.